Two Sigma Advisers’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,290
| Closed | -$46K | – | 2441 |
|
|
2025
Q1 | $46K | Sell |
7,290
-420
| -5% | -$2.65K | ﹤0.01% | 2324 |
|
|
2024
Q4 | $79.6K | Sell |
7,710
-1,496
| -16% | -$15.4K | ﹤0.01% | 2246 |
|
|
2024
Q3 | $118K | Sell |
9,206
-4,426
| -32% | -$56.9K | ﹤0.01% | 2149 |
|
|
2024
Q2 | $189K | Buy |
13,632
+10,754
| +374% | +$149K | ﹤0.01% | 2230 |
|
|
2024
Q1 | $895K | Buy |
2,878
+1,864
| +184% | +$580K | ﹤0.01% | 1634 |
|
|
2023
Q4 | $266K | Buy |
+1,014
| New | +$266K | ﹤0.01% | 2144 |
|
|
2023
Q2 | – | Sell |
-566
| Closed | -$56.9K | – | 2549 |
|
|
2023
Q1 | $56.9K | Sell |
566
-6
| -1% | -$603 | ﹤0.01% | 2438 |
|
|
2022
Q4 | $89.8K | Sell |
572
-284
| -33% | -$44.6K | ﹤0.01% | 2311 |
|
|
2022
Q3 | $214K | Buy |
856
+88
| +11% | +$22K | ﹤0.01% | 2178 |
|
|
2022
Q2 | $217K | Buy |
768
+368
| +92% | +$104K | ﹤0.01% | 2252 |
|
|
2022
Q1 | $80K | Sell |
400
-734
| -65% | -$147K | ﹤0.01% | 2534 |
|
|
2021
Q4 | $247K | Sell |
1,134
-26
| -2% | -$5.66K | ﹤0.01% | 2210 |
|
|
2021
Q3 | $529K | Buy |
1,160
+280
| +32% | +$128K | ﹤0.01% | 1908 |
|
|
2021
Q2 | $353K | Buy |
880
+251
| +40% | +$101K | ﹤0.01% | 2084 |
|
|
2021
Q1 | $364K | Buy |
+629
| New | +$364K | ﹤0.01% | 2146 |
|